Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Liquid Phase Peptide Synthesis (LPPS). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111253287A details a liquid-phase convergent synthesis for Semaglutide side chains, offering significant cost reduction and scalability for global pharmaceutical manufacturing supply chains.
Patent CN113698458A details a full liquid-phase method for triptorelin, offering high purity crude product and significant cost reduction in peptide manufacturing compared to solid-phase routes.
Patent CN116410260A reveals a high-purity liquid-phase synthesis for Fmoc-L-Orn(Boc)-Gly-OH, offering significant cost reduction in atosiban manufacturing and scalable production capabilities.